ATXI
Price
$1.84
Change
+$0.18 (+10.84%)
Updated
Dec 18 closing price
BETRF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

ATXI vs BETRF

Header iconATXI vs BETRF Comparison
Open Charts ATXI vs BETRFBanner chart's image
Avenue Therapeutics
Price$1.84
Change+$0.18 (+10.84%)
Volume$71.34K
CapitalizationN/A
BETTERLIFE PHARMA
Price$0.07
Change-$0.00 (-0.00%)
Volume$49.7K
CapitalizationN/A
ATXI vs BETRF Comparison Chart
Loading...
ATXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXI vs. BETRF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXI is a Buy and BETRF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ATXI: $1.84 vs. BETRF: $0.07)
Brand notoriety: ATXI and BETRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXI: 134% vs. BETRF: 191%
Market capitalization -- ATXI: $3.74M vs. BETRF: $9.53M
ATXI [@Biotechnology] is valued at $3.74M. BETRF’s [@Biotechnology] market capitalization is $9.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXI’s FA Score shows that 1 FA rating(s) are green whileBETRF’s FA Score has 0 green FA rating(s).

  • ATXI’s FA Score: 1 green, 4 red.
  • BETRF’s FA Score: 0 green, 5 red.
According to our system of comparison, BETRF is a better buy in the long-term than ATXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXI’s TA Score shows that 3 TA indicator(s) are bullish while BETRF’s TA Score has 3 bullish TA indicator(s).

  • ATXI’s TA Score: 3 bullish, 5 bearish.
  • BETRF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ATXI and BETRF are a bad buy in the short-term.

Price Growth

ATXI (@Biotechnology) experienced а -1.08% price change this week, while BETRF (@Biotechnology) price change was -0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

ATXI is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BETRF($9.53M) has a higher market cap than ATXI($3.74M). BETRF YTD gains are higher at: 50.125 vs. ATXI (-86.253). BETRF has higher annual earnings (EBITDA): -3.87M vs. ATXI (-9.52M). ATXI (0) and BETRF (0) have equivalent revenues.
ATXIBETRFATXI / BETRF
Capitalization3.74M9.53M39%
EBITDA-9.52M-3.87M246%
Gain YTD-86.25350.125-172%
P/E Ratio0.07N/A-
Revenue00-
Total Cash2.6MN/A-
Total Debt6.38MN/A-
FUNDAMENTALS RATINGS
ATXI vs BETRF: Fundamental Ratings
ATXI
BETRF
OUTLOOK RATING
1..100
728
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9246
P/E GROWTH RATING
1..100
9949
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATXI's Valuation (23) in the Pharmaceuticals Major industry is significantly better than the same rating for BETRF (100) in the null industry. This means that ATXI’s stock grew significantly faster than BETRF’s over the last 12 months.

ATXI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as BETRF (100) in the null industry. This means that ATXI’s stock grew similarly to BETRF’s over the last 12 months.

ATXI's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as BETRF (100) in the null industry. This means that ATXI’s stock grew similarly to BETRF’s over the last 12 months.

BETRF's Price Growth Rating (46) in the null industry is somewhat better than the same rating for ATXI (92) in the Pharmaceuticals Major industry. This means that BETRF’s stock grew somewhat faster than ATXI’s over the last 12 months.

BETRF's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for ATXI (99) in the Pharmaceuticals Major industry. This means that BETRF’s stock grew somewhat faster than ATXI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXIBETRF
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPEYX10.18N/A
N/A
MassMutual Strat Emerg Mkts Svc
GCTAX48.18N/A
N/A
Goldman Sachs US Tax-Managed Eq A
VCNIX29.32-0.13
-0.44%
VALIC Company I NASDAQ-100 Index
VEMPX374.01-4.38
-1.16%
Vanguard Extended Market Index InstlPlus
HWLZX41.55-0.51
-1.21%
Hotchkis & Wiley Large Cap Fdml Value Z

ATXI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXI has been closely correlated with ZVSA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATXI jumps, then ZVSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXI
1D Price
Change %
ATXI100%
-4.60%
ZVSA - ATXI
76%
Closely correlated
-2.43%
OMGA - ATXI
40%
Loosely correlated
+0.15%
CGEM - ATXI
35%
Loosely correlated
-2.63%
JSPR - ATXI
34%
Loosely correlated
+4.66%
BDRX - ATXI
31%
Poorly correlated
+0.96%
More

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and ATXI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and ATXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
-10.11%
ATXI - BETRF
21%
Poorly correlated
-4.60%
CLABF - BETRF
20%
Poorly correlated
+18.29%
AVCTF - BETRF
15%
Poorly correlated
N/A
ARTH - BETRF
5%
Poorly correlated
+16.67%
BSEM - BETRF
3%
Poorly correlated
-1.45%
More